Journal
PHYLOGENETIC ASPECTS OF NEUROPEPTIDES: FROM INVERTEBRATES TO HUMANS
Volume 1200, Issue -, Pages 120-127Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2010.05509.x
Keywords
ghrelin; GHS-R; cachexia; growth hormone; obesity
Categories
Funding
- JSPS KAKENHI [20659131]
Ask authors/readers for more resources
Gastrointestinal peptides play important roles regulating feeding and energy homeostasis. Most gastrointestinal peptides including glucagon like peptide-1, peptide YY, amylin, and oxytomodulin are anorectic, and only ghrelin is an orexigenic peptide. Ghrelin increases appetite, modulates energy balance, suppresses inflammation, and enhances growth hormone secretion. Given its diversity of functions, ghrelin is expected be an effective therapy for lean patients with cachexia caused by chronic heart failure, chronic respiratory disease, anorexia nervosa, functional dyspepsia, and cancer. Clinical trials have demonstrated that ghrelin effectively increases lean body mass and activity in cachectic patients. Ghrelin interrupts the vicious cycle of the cachectic paradigm through its orexigenic, anabolic, and anti-inflammatory effects, and ghrelin administration may improve the quality of life of cachectic patients. We discuss the significant roles of ghrelin in the pathophysiology of cachectic diseases and the possible clinical applications of ghrelin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available